Tom Lilly Stephen

Activist
DISC Type : Cd

Founder at NewCo (stealth)

Greater Boston, United States

Overview

Tom Lilly Stephen is an immuno-oncologist with 20 years of research experience in anti-tumor immunity and drug resistance. As a founder of multiple biotech companies, including Jeevan Therapeutics and a stealth-mode venture, he focuses on developing innovative drugs for unmet patient needs. He holds a PhD from the University of Cologne.

He is deeply engaged in the biotech ecosystem, actively attending events like the Boston Biotech Investor Day and following industry trends. Tom shows a keen interest in the journey of startups, from building and funding to scaling, and closely follows strategic collaborations within the biopharmaceutical space.

He has co-authored research on how the SATB1 protein governs the epigenetic repression of PD-1 in T cells, a key pathway in cancer immunity.

Personality Overview

Observative

Perfectionist

Meticulous

They don’t always try to control the conversation but neither do they like yielding it fully.  They care equally about the product and its potential impact. They focus on objectivity in a pitch and pay little attention to bells and whistles.

Topics They Care About

Immuno-Oncology Resistance
His career is dedicated to investigating anti-tumor immunity, the tumor microenvironment, and developing drugs to overcome resistance.
Biotech Entrepreneurship
As a founder of multiple ventures, he is passionate about building, funding, and scaling biotech startups, and follows related educational opportunities like startup academies.
Antibody Drug Development
His work at Jeevan Therapeutics involves creating novel antibody-drug conjugates (ADCs) for colorectal cancer and autoimmune conditions.

Media Appearances

Tom has no verified media appearances

Work History

8-2025
Founder at NewCo (stealth)
9-2024
CORUM Member at University of Massachusetts Amherst
5-2024 - 7-2025
Co-Founder, President, and Executive Board Member at Jeevan Therapeutics, Inc.
4-2023 - 5-2024
Co-Founder (Stealth) at Jeevan Therapeutics, Inc.
11-2020 - 3-2023
Senior Principal Scientist at HiFiBiO Therapeutics

Education

2002 - 2005
PhD from University of Cologne
6-1996 - 7-1999
Master of Science - MS from Manipal Academy of Higher Education

More Information

Social Presence :

Prographics :

Exp : 6 Location : Greater Boston, United States Job Level : Leadership Designation : Founder at NewCo (stealth)
URL has been copied!

Insights For Selling To Tom Lilly

During A Call Or A Meeting

DO's

  • Ask them questions confidently while doing discovery, don’t be apologetic
  • Be crisp while making the pitch
  • Make sure that you you respond to any queries from them quickly

DONT's

  • Avoid long winding pitches, stay objective
  • Don’t expect them to change their mind quickly if they say no once
  • Don't try too hard to get friendly, let it happen with time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Tom Lilly is

  • Belief in the product plays an important role, followed by objective proof and testimonials.
  • Will you ever get a clear answer from Tom Lilly

  • They may hesitate slightly, but if they are not convinced, they will say no.

Insights For Deal Planning

    How fast (or slow) will Tom Lilly move?

  • Their decision making speed is somewhere in the middle.
  • Can Tom Lilly take some risk or not?

  • They can take risks only after they have analyzed the advantages and disadvantages.

You And Tom Lilly

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.